chrisvoncsefalvay/vaers-outcomes huggingface dataset:
has a whole lot of fluid; was weak and all sorts of a mess/Had been really weak; This is a spontaneous report from a contactable consumer (patient's wife) via a medical information team. An 85-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: Not Provided, NDC number: Not Provided, Expiration date: Not Provided), via an unspecified route of administration on 05Feb2021 at single dose for COVID-19 immunisation. The patient's medical history included sick prior to receiving the vaccine. Concomitant medications were not reported. It was reported that, caller (75-year-old, female) and husband received the first dose of the COVID vaccine on 05Feb2021. Caller has information that the vaccination center provided that states, "you should receive your second dose between 26Feb2021 and 01Mar2021. You should receive your second dose for maximum protection. Follow-up to receive the second dose." Caller asked, "where do I need to get the second shot". Caller stated that she took her husband to the hospital on Wednesday. Caller states that her husband was already sick prior to receiving the vaccine and the hospital admission was "not from the vaccine." Caller states that her husband "was weak and all sorts of a mess on an unspecified date in Feb2021." Caller states that "they drained fluid out of him yesterday (on an unspecified date in Feb2021) and he should be home sometime by the end of next week." Caller was a woman who was calling to seek information about where her and her husband could go to get the second dose of the COVID vaccine. Caller states that her husband was in the hospital, but he should be home some time. Caller stated she needs to know where she can take her husband to get the second dose of the vaccine. Caller reports her husband has been in the hospital on an unspecified date in Feb2021 because he has a whole lot of fluid on an unspecified date in Feb2021. Caller states that her husband has been sick for a while, and on Wednesday she took him to the hospital. Caller reports that the hospital called her yesterday and they said they had to drain a lot of fluid out of him, and they wanted to keep him. Caller states that he had been really weak on an unspecified date in Feb2021. Caller states that this doesn't really have anything to do with the COVID vaccine. The event has a whole lot of fluid was considered as serious (hospitalization) by the consumer. The outcome of the events was unknown.   Information on the lot/ batch number has been requested.
Chills, shakes, fever 102, nausea, weakness, dizziness  fever broke at midnight.  Next day was listless and achy.  On 10/10/2014 was back to normal.
Information has been received from a registered nurse concerning her 84 year old father with multiple medical problems who in 1995 was vaccinated with a dose of PNEUMOVAX 23 (lot, route and site of administration not reported). The nurse reported that her father may have had aspiration pneumonia when he died on 27-JUL-2000. Her father was a hospice patient at the time of his death. The registered nurse felt that her father's death and aspiration pneumonia were not related to therapy with PNEUMOVAX 23. No further information is available. 11/16/09 Certificate of Death received. DOD 7/27/2000. Cause of Death: Alzheimers Disease.
04/09/21 @ 5:30 pm:  sore throat, congestion / 7:30 pm: fever, chills, body aches, headache, dry cough added. Temp was 99 04/10/21: All of the above plus no energy at all, nausea, and a mucus cough. It was an effort to get out of bed to use the bathroom. Temp was anywhere from 101 to 103 throughout the day. Wheezing  and shortness of breath started about 10 am and I had to use the inhaler more than once. 04/11/21: Same as 04/10/11. Temp was between 100 and 102 04/12/21: Dry cough, low grade fever, headache, body chills, lethargic.  Covid test taken.  04/13/21: Dry cough, headache, sore throat, shortness of breath, lethargic. Inhaler still being used.
A few days after vaccine patient developed chest pain.  Had heart attack at doctors visit on 9/21 and is currently in hospital due to heart attack.
Felt ill, then palm of hand got itchy and developed nerve pain all the way down arm. Throbbing nerve pain.
Subject states she received the vaccine on 12/30/20 to her right arm.  On 1/7/21 she noticed her arm was still sore and her lymph node in her armpit was swollen.  As of 1/15/21 she stated the symptoms lasted about a week but have now just recently resolved
One day after first vaccine on January 20, 2021, experienced severe chills for 30 minutes - cold and shaking. No medicine was taken for this. Second vaccine was on February 21, 2021 and nearly two weeks after this, experienced the same thing - chills for no more than 30 minutes. No medicine was taken for this.
3 shot 17Aug21; 3 shot 17Aug21; Shot site itchy blister with a pimple like center; Shot site itchy blister with a pimple like center; Very sick for 2 days; High fever; Worst headache for several days; Muscle/joint aches; Muscle/joint aches; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received third dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC 3181) after complete initial immunization, via an unspecified route of administration on 17Aug2021 as dose 3 (booster), single for COVID-19 immunization. The medical history included transient ischaemic attack in Feb2019 (two years ago) and subsequent problems with blood pressure. The patient concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FC 9581), via an unspecified route of administration on 09Mar2021 as dose 1, single and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN 620), via an unspecified route of administration on 02Mar2021 as dose 2, single both for COVID-19 immunization. The patient mentioned she felt bad for 1day after taking the 2nd dose. On an unspecified date in 2021 after third shot patient was very sick for 2 days, shot site itchy blister with a pimple like center, high fever, worse headache ever for several days and muscle/joint aches. She stayed in bed for 2 days and she could not take care of herself. Outcome of the events "very sick for 2 days" and "worst headache for several days" recovered in unspecified date in 2021 and for other events it was unknown.  Follow-up (02Sep2021): The initial case was missing the following minimum criteria: No Adverse Effect. Upon receipt of follow-up information on (01Sep2021), this case now contains all required information to be considered valid.  Follow-up attempts are completed. No further information is expected.
Post Second shot ( 2-15-2021):  Sore arm, tired, achy  April 1/2021- AFIB first noticed.  Saw doctor that day. EKG test. Later appointment with a cardiologist for other tests.:   Heart palpitations/afib: Encounter for screening for cardiovascular disordersInconclusive results.   Only 3-4 other very light afib events that went away in about an hour or two.
Fever, chills and shortness of breath occurred approximately 23 hours after administration. Went to ED and was released to home.
Right arm hurts, patient says can't lift arm above the shoulder. Arm throbs, no swelling. After 2 hours post injection no swelling or redness of site - just soreness.
My throat tounge and feet swelled up like balloons including half of my lungs was sent to facility doctor where he said it's a normal reaction. Since then I have developed a ball on the right side of my throat and have no energy what so ever I'm all of a sudden allergic to things I never was and prone to getting sick
PATIENT RETURNED TO PHARMACY APPROX 3 HOURS AFTER RECEIVING 2ND DOSE OF MODERNA VACCINE. ( SHE IS AN ASSOCITAE WITHIN  OUR STORE) AND COMPLAINED OF ITCH AND ARM SORENESS, NO SWELLING OF LIPS OR TONGUE UPON EXAMINING HER, SHE STATED SHE FELT A BIT ANXIOUS AND WARM ,  I RECOMMENDED TRYING AN ANTIHISTAMINE FOR ITCH , EXPALINED TO HER THAT MAYBE SHE SHOULD SHOULD  CONTACT STORE MANAGER AND POSSIBLY LEAVE FOR DAY. ASSISATANT MANAGER WAS NOTIFIED AND DISCUSSED OPTIONS.
Patient called our clinic on 8.7.08 reporting she had some pain and swelling and "red rash"in her left arm in which a TDAP and Twinrix (Hepatitis A and Hepatitis B) shots were administered on 8.1.08. Client came into our clinic on that day and I observed a red rash on patient's left shoulder. Patient denies having fever.
11-1-07 9pm Fever of 101.7 - c/o violent chills that felt like convulsions - joint pain in elbow, shoulder, knuckles, and neck - took aspirin before going to bed but does not remember exact time.  11-2-07 7:50am  Continues to c/o fever of 100 - back muscles are very sore and joints continue to ache.  Has not taken any further medication. 11-5-07 10am Reports that he is feeling better - no complaints.
Edema of left axilla, pain in left breast @ 2 a.m. which has continued following injection, ecchymosis along the left lymphatic system from left axilla, medial aspect of left breast, and anterior medial aspect of left arm which began 2nd day.   Other symptoms included headache, back pain, rigors, fever, diaphoresis, chills, and myalgia.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated with lot # (669776/0614AA), 1 DF PNEUMOVAX23. No other co-suspects were reported. No concomitant medications were reported. On 01-OCT-2012 the patient experienced expired vaccine used. No treatment information was reported. The outcome of expired vaccine used is unknown. Expired vaccine used is not related to PNEUMOVAX23. {Additional information has been requested. /Additional information is not expected.}
Information has been received from a hospital worker concerning a patient who in February 2001, was vaccinated with Pneumococcal vaccine 23 polyvalent. Subsequently the patient experienced blood clots. Unspecified medical attention was sought. No other Info was available. Upon internal review, blood clots were considered to be an Other Important Medical Event. Follow up on 06/29/2001: "Patient date of birth and age at time of vaccination is not provided."
This spontaneous report has been received from a Licensed Practical Nurse referring to an unspecified  patients of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions, drug, allergy history or concomitant medications. The reporter stated that from 15-AUG-2017 to 18-SEP-2017, the patients were vaccinated with improperly stored doses of ROTATEQ, orally (strength and dose were not provided) lot# M040269 with expiration date 28-APR-2018, and lot # M043563, with expiration date 09-JUN-2018,  for prophylaxis. The doses of ROTATEQ, were exposed to a temperature excursion of 47°Fahrenheit (°F) to 77°F during a time frame of 2 hours and 18 minutes, which was detected by the data logger. There was no previous temperature excursion. No adverse effects were reported.
approx 4hr p/vax mom reports that pt lips began to quiver;this progressed to whole body quivering for about 8min;afeb;no problems since that time;
Developed 4 itchy bumps on left side of back a few days after vaccines. Resolved after approx week.
After receiving vaccine, I was working in the yard, removing trees and could not catch my breath.  After a certain point, I sat down and it took about 30 minutes to start to breath normal.  Caught covid at end of December and had pneumonia.  Doctor also said I had a-fib.  Never had this issue before the shot.  Spent 9 days in bed with fever (102-103) then went to emergency and was admintted to the hospital.  There I found out I had a-fib.  Pulse rate ranges from 54 to 120 with the highest of 172 (only measured once).  I now take cardizem and another heart/bp medicine plus lasix, xeralto, potasium, and other vitamins.
first dose 9/21 but didn't get second dose; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (8 times prior to this reporting).   In September 2021, the patient received the 1st dose of Shingles vaccine. On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. In July 2022, less than a year after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 1-Aug-2022 Reporter's comments: This case was reported by consumer via interactive digital media. The patient received 1st dose of the vaccine in September 2021 but did not get the second dose. The patient broke out with shingles this week. The patient wanted to ask how long patient should wait before getting the vaccine. Also wanted to ask patient would need 2 doses or just one. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination. The follow up would not possible since contact details were not provided.
This case was reported by a physician and described the occurrence of increased lymph node size in a subject of unspecified age and gender who was vaccinated with FLUARIX, (GlaxoSmithKline). On an unspecified date, the subject received unspecified dose of FLUARIX (.5 ml, intramuscular, unknown deltoid and batch number). In September 2014, at an unspecified time after vaccination with FLUARIX, the subject experienced increased lymph node size and increased lymph node tenderness in the axillary area. It was unknown if the events were localized to the arm of vaccination. At the time of reporting, the outcome of the events was unspecified. This is one of the 3 cases reported by the same reporter for the same vaccine and same events. Follow-up received on 25 September 2014. This case was reported by a physician and described the occurrence of enlargement of lymph nodes in a female patient who received Influenza vaccine. On an unknown date, the patient received Influenza vaccine (intramuscular) .5 ml. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced enlargement of lymph nodes. On an unknown date, the outcome of the enlargement of lymph nodes was unknown. It was unknown if the reporter considered the enlargement of lymph nodes to be related to Influenza vaccine. Additional information: The patient was the physician herself.
vomitting, nausea, extreme muscle soreness-whole body, extreme joint pain, extreme head ache, skin hurt to touch, fever, extreme fatigue
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 67-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 18-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250795, expiry date: 30-Apr-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805450 was crossed linked to original case 201804863 due to same reporter.
pt was sitting and given the injection.  She then complained that she had a hot sensation in her body which moved up to her head.   I laid her down and the sensation passed  vital signs remained normal  Unable to enter Manufacture GSK
This case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a female patient who received Shingrix for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date without a knot at injection site). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site lump. On an unknown date, the outcome of the injection site lump was unknown. It was unknown if the reporter considered the injection site lump to be related to Shingrix. Additional details were received as follows: This case was reported by the patient's husband. The age at vaccination was not reported. The reporting healthcare professional (HCP) administered the Shingrix to the patient. The patient developed a knot at the injection site. The reporter stated that, the patient did not experience a knot at injection site after the 1st dose of Shingrix. Hence, the HCP asked if it was his technique that caused his wife to get a knot at injection site.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (patient in this report did not experience any side effects) in a 9-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Feb-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (patient in this report did not experience any side effects). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (patient in this report did not experience any side effects) outcome was unknown.
Patient had a syncopal episode after receiving vaccine. Patient reported feeling dizzy and weak and appeared slightly pallid. She was given an ice pack, water, and a popsicle. Patient had not eaten or had anything to drink for several hours prior to vaccination. Blood pressure, pulse, and respirations were all within normal limits. Patient was alert and oriented x4. Symptoms resolved within 25 minutes. Patient continued in observation for an additional 15 minutes and then left was able to walk out with her mom.
Pt vacc. /w DTP 24 hrs later child died. Child had URI, /p shot fever, she fed normally 8 hrs before death. In AM mother went to dress child, child blinked, gasped & then arrested. F/U DR called 30Oct90 lab data not consistant /w moms hx
This spontaneous report has been received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # M042858, expiration date 21-OCT-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 15 to 46 degrees Fahrenheit (F) (35 (F)) for 10 hours. Digital data logger was not involved. There were no previous excursions reported. No product quality complaint was involved. Additional information has been requested.
MUSCLE ACHE; CHILLS; FATIGUE; This spontaneous report received from a patient concerned a 43 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced muscle ache. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue, muscle ache, and chills. This report was non-serious. This case, from the same reporter is linked to 20210411696.
weakness of the muscle in the upper arm (cannot lift arm over her head); discomfort on her hips down to her knees; soreness of the muscle in the upper arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)), DISCOMFORT (discomfort on her hips down to her knees) and MYALGIA (soreness of the muscle in the upper arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)) and DISCOMFORT (discomfort on her hips down to her knees). 19-Mar-2021, the patient experienced MYALGIA (soreness of the muscle in the upper arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCULAR WEAKNESS (weakness of the muscle in the upper arm (cannot lift arm over her head)), DISCOMFORT (discomfort on her hips down to her knees) and MYALGIA (soreness of the muscle in the upper arm) had not resolved.            This case was linked to MODERNATX, INC.-MOD-2021-067210 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2021-067210:1st dose
knocked me on my ass; This case was reported by a consumer and described the occurrence of debility in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced debility. On an unknown date, the outcome of the debility was unknown.   It was unknown if the reporter considered the debility to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. Patient mentioned that shingles shot were two shot series and basically 95 percent effective,however Patient received the Shingrix and patient knocked on ass for about 1 1/2 days.
11/15/2021- I developed a rash on my right arm. 11/15/2021- I went to the Immediate Care. The doctor said don't worry about it. It is probably an allergy and prescribed Benadryl. 11/18/2021- The rash is still going away slowly on my right arm.